Interpretation of Genotype and Pharmacokinetics for Resistance to Fosamprenavir-Ritonavir-Based Regimens in Antiretroviral-Experienced Patients

In this study, named the Zephir study (Telzir-pharmacokinetics), 121 antiretroviral-experienced human immunodeficiency virus (HIV) patients failing on highly active antiretroviral therapy (HAART) were included in a prospective cohort and received a fosamprenavir-ritonavir (700 mg/100 mg twice a day)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pellegrin, Isabelle, Breilh, Dominique, Coureau, Gaelle, Boucher, Sébastien, Neau, Didier, Merel, Patrick, Lacoste, Denis, Fleury, Hervé, Saux, Marie-Claude, Pellegrin, Jean-Luc, Lazaro, Estibaliz, Dabis, François, Thiébaut, Rodolphe
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2007
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1855517/
https://ncbi.nlm.nih.gov/pubmed/17296739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00481-06
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak